Georgia Tech names new director for Advanced Technology Development Center
Tuesday, November 06, 2018 10:05 AM

Georgia Tech said Monday it's named John Avery as its next director of its Advanced Technology Development Center (ATDC) business incubator.

The announcement follows a four-month national search for a new leader at ATDC following the departure of Jen Bonnett, who left in June 2018 to become the Savannah Economic Development Authority’s vice president of innovation and entrepreneurship.

Most recently, Avery -- a Georgia Tech graduate -- was engineering group manager of Panasonic Automotive Systems’ Panasonic Innovation Center at the Georgia Tech campus.

As director of the ATDC, Avery will lead a team of 26 full- and part-time staff and advisors who run ATDC’s various initiatives. Read the complete announcement here.

In 2017, ATDC worked with more than 1,838 entrepreneurs across the state of Georgia. Its portfolio companies and program graduates received more than $823 million in capital investments, reported more than $148 million in revenue, and supported 2,260 jobs.

Read more...
 
Shire Files Submission for U.S. FDA Approval to Manufacture FLEXBUMIN® at New Plasma Manufacturing Facility near Covington, Georgia
Thursday, November 01, 2018 11:09 AM

Dublin, Ireland – October 25, 2018 – Shire plc (Shire) (LSE: SHP, NASDAQ: SHPG), the leading global biotechnology company focused on rare diseases, today announced that it has filed its second submission to the United States Food and Drug Administration (FDA) for its new plasma manufacturing facility near Covington, Georgia.

This second submission is for the manufacturing of FLEXBUMIN 25% [Albumin (Human)], USP, 25% Solution, a treatment primarily used as plasma-volume replacement therapy in immune disorders, trauma and other critical conditions. The Georgia facility received its first FDA approval, to manufacture GAMMAGARD LIQUID [Immune Globulin Infusion (Human)] 10% Solution.

“We are very pleased to file this second submission for our state-of-the-art manufacturing facility in Georgia, after the facility received FDA approval earlier this year,” said Matt Walker, Head of Technical Operations for Shire. “Expanding our capacity for manufacturing FLEXBUMIN will allow us to better meet the increasing global demand for plasma protein therapies and further supports our growing immunoglobulin and bio-therapeutics portfolio by enabling us to deliver these important treatments to our patients.”

Read more...
 
GeoVax Announces Further Positive Results of its HIV Preventive Vaccine Program at International HIV Research Conference
Wednesday, October 24, 2018 10:43 AM

Booster Vaccination After ~7 Years Resulted in 600-fold Increase in Antibody Response

Atlanta, GA - (NewMediaWire) - October 24, 2018 - GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today announced the presentation of positive results from HVTN 114, a phase 1 trial testing a late protein boost of participants from a phase 2a trial of GeoVax’s GOVX-B11 preventive HIV vaccine candidate. The presentation was made by the Protocol Chair, Paul A. Goepfert, M.D., University of Alabama, during the HIV Research for Prevention (HIVR4P) conference in Madrid, Spain. HVTN 114 was conducted by the HIV Vaccine Trials Network (HVTN) through the support of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). 

GOVX-B11 consists of two experimental vaccine components – a recombinant DNA component and a recombinant live MVA (modified vaccinia Ankara) virus component. Both components produce non-infectious virus-like-particles (VLPs) in the cells of the vaccinated, HIV-negative, person.

Read more...
 
Georgia nonprofit launches with aim of protecting statewide intellectual property
Tuesday, October 23, 2018 09:01 AM

The Georgia Intellectual Property Alliance officially launched Monday as a nonprofit designed to serve the state by establishing a better model for creating, protecting and enabling intellectual property.

GIPA has created a coalition of education institutions, world-leading research labs, innovation-focused organizations, companies ranging from Fortune 500s to startups and other creators to collaborate on the initiative. The organization will focus on accelerating the market launch of ideas that serve the common good, while specializing in protecting IP, including patents, copyrights, trademarks and trade secrets, according to a news release.

Gov. Nathan Deal officially proclaimed October 2018 as “Intellectual Property Month,” in recognition of GIPA and the critical importance of IP to the growth and success of the state’s economy.

Read more...
 
Alpharetta company acquires biomedical firm in Tampa
Monday, October 22, 2018 10:05 AM

A medical technology company out of Alpharetta has acquired Tampa-based Regenerative Medicine Solutions LLC, a biomedical services company in an all-stock transaction. 

Medovex Corp. was formed to acquire and develop a portfolio of medical tech products and services with disruptive characteristics, the statement said. RMS manages Lung Health Institute, which specializes in cellular therapies to treat chronic obstructive pulmonary disease and other chronic lung disorders.

Bill Horne, and founder and former CEO of Laser Spine Institute, is Medovex’s new CEO and chairman of the board of directors as of Oct. 9. Jarrett Gorlin resigned as president and CEO, a filing with the U.S. Securities and Exchange Commission said.

Read more...
 
<< first < Prev 1 2 3 4 5 6 7 8 9 10 Next > last >>

Page 4 of 37